Cargando…
Distribution and concordance of PD-L1 expression by routine 22C3 assays in East-Asian patients with non-small cell lung cancer
BACKGROUND: Currently, programmed death ligand-1 (PD-L1) expression has been widely applied in clinical trials and real-world clinical practice as a major biomarker for the efficacy of immune-checkpoint inhibitors. The purpose of this study is to reveal the distribution and concordance of PD-L1 expr...
Autores principales: | Fu, Fangqiu, Deng, Chaoqiang, Sun, Wenrui, Zheng, Qiang, Jin, Yan, Li, Yuan, Zhang, Yang, Chen, Haiquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636784/ https://www.ncbi.nlm.nih.gov/pubmed/36335353 http://dx.doi.org/10.1186/s12931-022-02201-8 |
Ejemplares similares
-
Impact of Adjuvant Therapy on Survival in Surgically Resected Limited-Stage Small Cell Lung Cancer
por: Li, Di, et al.
Publicado: (2021) -
Prognostic effect of ground-glass opacity in subcentimeter invasive lung adenocarcinoma
por: Bai, Jinsong, et al.
Publicado: (2023) -
Tumor‐derived Vimentin as a novel biomarker for distinct subtypes predicting adjuvant chemotherapy resistance and T‐cell‐inflamed phenotype in small cell lung cancer
por: Deng, Chaoqiang, et al.
Publicado: (2023) -
Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma
por: Bai, Jinsong, et al.
Publicado: (2022) -
Systemic immune-inflammation index is a stage-dependent prognostic factor in patients with operable non-small cell lung cancer
por: Fu, Fangqiu, et al.
Publicado: (2021)